Office-Based Buprenorphine Treatment of Opioid Use Disorder (Online)-Module 3

Module 3 - Additional Resource (Slide Handout #3)

Pdf Summary

This document discusses the clinical management of patients receiving buprenorphine for the treatment of opioid use disorder in an office-based setting. It emphasizes the importance of building a trusting relationship with the patient and setting clear expectations from the beginning of treatment. Problematic behaviors, such as intoxication or drug diversion, are addressed with a proactive and consistent approach, including increased monitoring and referral to additional treatment resources if needed. Urine drug testing is also an integral part of treatment to monitor patient progress and adherence to treatment. The document provides guidance on conducting urine testing and highlights the importance of having established rules and regulations in place to address problematic behaviors. Overall, the document emphasizes the need for open communication, consistency in approach, and flexibility in responding to challenges that may arise during treatment.

Keywords

clinical management

buprenorphine

opioid use disorder

office-based setting

trusting relationship

problematic behaviors

urine drug testing

monitoring

referral

treatment resources